|
PROBENECID COMPETITIVELY INHIBITS TUBULAR SECRETION & THUS INHIBITS RENAL EXCRETION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
LAMIVUDINE SIGNIFICANTLY INHIBITED PHOSPHORYLATION OF ZALCITABINE IN DOSE DEPENDANT MANNER & HENCE ITS EFFICACY. CONCOMITANT USE NOT RECOMMENDED
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
INCREASED CHANCES OF ACUTE PANCREATITIS
|
DOXORUBICIN SIGNIFICANTLY INHIBITED PHOSPHORYLATION OF ZALCITABINE IN DOSE DEPENDANT MANNER & HENCE ITS EFFICACY. CONCOMITANT USE NOT RECOMMENDED
|
CO-ADMINISTRATION CAN REDUCE ZALCITABINE ABSORTION FROM THE GUT
|